Padlock Therapeutics Investor Relations Manager Salaries in Boulder | Comparably
Padlock is developing medicines targeting PADs, immune complexes in autoimmune diseases, and more. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
95

Padlock Therapeutics Investor Relations Manager Salaries in Boulder

The average Padlock Therapeutics Investor Relations Manager in Boulder earns an estimated $99,779 annually. Padlock Therapeutics' Investor Relations Manager compensation is $12,476 more than the US average for a Investor Relations Manager.

In Boulder, The Communications Department at Padlock Therapeutics earns $2,148 more on average than the Enterprise Risk Department.

Last updated 5 years ago.

$51k
$64k
$75k
$85k
$114k
$175k
$99,779
Average Compensation
$99,779
avg. base

Investor Relations Manager Salaries at Padlock Therapeutics

* estimated salary

Compensation at Padlock Therapeutics by Department

In Boulder, The Communications Department averages $2,148 more than the Enterprise Risk Department.

Communications
$189,266 Avg. total comp.
Enterprise Risk
$187,118 Avg. total comp.
-$2k
Product
$151,754 Avg. total comp.
-$38k

Investor Relations Manager Compensation by Gender (All Companies)

The average female Investor Relations Manager at companies similar size to Padlock Therapeutics reported making $152,500, while the average male Investor Relations Manager at similar sized companies reported making $75,500.

Investor Relations Manager Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Investor Relations Manager at companies similar size to Padlock Therapeutics reported making $175,000, while the average Caucasian Investor Relations Manager at similar sized companies reported making $70,250.

How Investor Relations Managers at Padlock Therapeutics Rate Their Compensation

The majority of Investor Relations Managers at Padlock Therapeutics believe they're compensated fairly. 50% of Investor Relations Managers at Padlock Therapeutics say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Padlock Therapeutics

×
Rate your company